IGF2BP1 and osteosarcoma: Similarly, Zhou and Xu showed that BMSC-derived exosomes inhibited osteosarcoma progression by transferring miR-1913 or miR-150 to osteosarcoma cells to suppress NRSN2 or IGF2BP1 expression, respectively [72,74].